Caveolin-1 in diagnosis and prognosis of canine mammary tumours: Comparison of evaluation systems

Journal of Comparative Pathology

Volumn 143, Issue 2-3, 2010, Pages 87-93

  Dias Pereira, P ^a   Lopes, C C ^a   Matos, A J F ^a   Cortez, P P ^a   Gartner F ^a   Medeiros, R ^a,b   Lopes, C ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Caveolin 1; Dog; Mammary gland neoplasia; Prognosis

Indexed keywords

CAVEOLIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; BREAST METASTASIS; BREAST TUMOR; CANCER DIAGNOSIS; CONTROLLED STUDY; DOG; GENETIC ASSOCIATION; INTERMETHOD COMPARISON; MALIGNANT NEOPLASTIC DISEASE; MAMMARY GLAND; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM;

ANIMALS; CARCINOMA; CAVEOLAE; CAVEOLIN 1; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; RESEARCH DESIGN; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

CANIS FAMILIARIS;

EID: 77954897337     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2010.01.002     Document Type: Article

References (31)

1. Adriance M., Inman J., Peterson O., Bissell M. Myoepithelial cells: good fences make good neighbors. Breast Cancer Research 2005, 7:190-197.
2. Amorim I., Lopes C., Faustino A., Dias Pereira P. Immunoexpression of caveolin-1 in canine normal and neoplastic mammary tissue. Journal of Comparative Pathology 2010, 143:39-44.
3. Bertucci F., Finetti P., Cervera N., Charafe-Jauffret E., Buttarelli M., et al. How different are luminal A and basal breast cancers?. International Journal of Cancer 2009, 124:1338-1348.
4. Burgermeister E., Liscovitch M., Rocken C., Schmid R., Ebert M. Caveats of caveolin-1 in cancer progression. Cancer Letters 2008, 268:187-201.
5. Charafe-Jauffret E., Ginestier C., Monville F., Finetti P., Adélaïde J., et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2005, 25:2273-2284.
6. Cohen A., Hnasko R., Schubert W., Lisanti M. Role of caveolae and caveolins in health and disease. Physiological Reviews 2004, 84:1341-1379.
7. Elsheikh S., Green A., Rakha E., Samaka R., Ammar A., et al. Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. British Journal of Cancer 2008, 99:327-334.
8. Goetz J., Lajoie P., Wiseman S., Nabi I. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Reviews 2008, 27:715-735.
9. Guarino M. Epithelial-mesenchymal transition and tumour invasion. International Journal of Biochemistry and Cell Biology 2007, 39:2153-2160.
10. Guarino M., Rubino B., Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007, 39:305-318.
11. Hnasko R., Lisanti M. The biology of caveolae: lessons from caveolin knockout mice and implication for human disease. Molecular Interventions 2003, 3:445-464.
12. Hugo H., Ackland M., Blick T., Lawrence M., Clements J., et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. Journal of Cellular Physiology 2007, 213:374-383.
13. Joshi B., Strugnell S., Goetz J., Kojic L., Cox M., et al. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. Cancer Research 2008, 68:8210-8220.
14. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958, 53:457-481.
15. Lakhani S., O'Hare M. The mammary myoepithelial cell - Cinderella or ugly sister?. Breast Cancer Research 2000, 3:1-4.
16. Liedtke C., Kersting C., Burger H., Kiesel L., Wulfing P. Caveolin-1 expression in benign and malignant lesions of the breast. World Journal of Surgical Oncology 2007, 5:110.
17. Lisanti M., Scherer P., Tang Z., Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends in Cell Biology 1994, 4:231-235.
18. Lu Z., Ghosh S., Wang Z., Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 2003, 4:499-515.
19. Misdorp W., Else R., Hellmen E., Lipscomb T. Histological Classification of Mammary Tumours of the Dog and the Cat 1999, Armed Forces Institute of Pathology, Washington, DC, pp. 1-59. 2nd Edit.
20. Navarro A., Anand-Apte B., Parat M. A role for caveolae in cell migration. FASEB Journal 2004, 18:1801-1811.
21. Okamoto T., Schlegel A., Scherer P., Lisanti M. Caveolins, a family of scaffolding proteins for organizing " preassembled signalling complexes" at the plasma membrane. Journal of Biological Chemistry 1998, 273:5419-5422.
22. Park S., Kim J., Kim Y.A., Kim Y.C., Kim S. Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast. Histopathology 2005, 47:625-630.
23. Pinilla S., Honrado E., Hardisson D., Benitez J., Palacios J. Caveolin-1 expression is associated with basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Research and Treatment 2006, 99:85-90.
24. Razani B., Schlegel A., Liu J., Lisanti M. Caveolin-1, a putative tumor suppressor gene. Biochemical Society Transactions 2001, 29:494-499.
25. Razani B., Woodman S., Lisanti M. Caveolae: from cell biology to animal physiology. Pharmacological Reviews 2002, 54:431-467.
26. Rothberg K., Heuser J., Donzell W., Ying Y., Glenney J., et al. Caveolin, a protein component of caveolae membrane coats. Cell 1992, 68:673-682.
27. Savage K., Lambros M., Robertson D., Jones R., Jones C., et al. Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Human Cancer Biology 2007, 13:90-101.
28. Shatz M., Liscovitch M. Caveolin-1: a tumor-promoting role in human cancer. International Journal of Radiation Biology 2008, 84:177-189.
29. Sørlie T., Wang Y., Xiao C., Johnsen H., Naume B., et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 2006, 7:127.
30. Williams T., Lisanti M. Caveolin-1 in oncogenic transformation, cancer, and metastasis. American Journal of Physiology - Cell Physiology 2005, 288:C494-C506.
31. Yang G., Truong L., Timme T., Ren C., Wheeler T., et al. Elevated expression of caveolin is associated with prostate and breast cancer. Clinical Cancer Research 1998, 4:1873-1880.